NRX Pharmaceuticals
NRXP
NRXP
25 hedge funds and large institutions have $2.31M invested in NRX Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
39% more funds holding
Funds holding: 18 → 25 (+7)
2.03% more ownership
Funds ownership: 6.64% → 8.67% (+2%)
Holders
25
Holding in Top 10
1
Calls
$45K
Puts
$6K
Top Buyers
| 1 | +$397K | |
| 2 | +$181K | |
| 3 | +$94.9K | |
| 4 |
Millennium Management
New York
|
+$60.8K |
| 5 |
Squarepoint
New York
|
+$55.7K |
Top Sellers
| 1 | -$59.2K | |
| 2 | -$6.8K | |
| 3 | -$4.3K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.1K |
| 5 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$79 |